HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation.

Abstract
Human mutations in PRKAG2, the gene encoding the gamma2 subunit of AMP activated protein kinase (AMPK), cause a glycogen storage cardiomyopathy. In a transgenic mouse with cardiac specific expression of the Thr400Asn mutation in PRKAG2 (TG(T400N)), we previously reported initial cardiac hypertrophy (ages 2-8 weeks) followed by dilation and failure (ages 12-20 weeks). We sought to elucidate the molecular mechanisms of cardiac hypertrophy. TG(T400N) mice showed significantly increased cardiac mass/body mass ratios up to approximately 3-fold beginning at age 2 weeks. Cardiac expression of ANP and BNP were approximately 2- and approximately 5-fold higher, respectively, in TG(T400N) relative to wildtype (WT) mice at age 2 weeks. NF-kappaB activity and nuclear translocation of the p50 subunit were increased approximately 2- to 3-fold in TG(T400N) hearts relative to WT during the hypertrophic phase. Phosphorylated Akt and p70S6K were elevated approximately 2-fold as early as age 2 weeks. To ascertain whether these changes in TG(T400N) mice were a consequence of increased AMPK activity, we crossbred TG(T400N) with TG(alpha2DN) mice, which express a dominant negative, kinase dead mutant of the AMPK alpha2 catalytic subunit and have low myocardial AMPK activity. Genetic reversal of AMPK overactivity led to a reduction in hypertrophy, nuclear translocation of NF-kappaB, phosphorylated Akt, and p70S6K. We conclude that inappropriate activation of AMPK secondary to the T400N PRKAG2 mutation is associated with the early activation of NF-kappaB and Akt signaling pathway, which mediates cardiac hypertrophy.
AuthorsSanjay K Banerjee, Kenneth R McGaffin, Xueyin N Huang, Ferhaan Ahmad
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1802 Issue 2 Pg. 284-91 (Feb 2010) ISSN: 0006-3002 [Print] Netherlands
PMID20005292 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 Elsevier B.V. All rights reserved.
Chemical References
  • DNA Primers
  • NF-kappa B
  • Threonine
  • RNA
  • Asparagine
  • PRKAG2 protein, human
  • AMP-Activated Protein Kinases
Topics
  • AMP-Activated Protein Kinases (chemistry, genetics, metabolism)
  • Amino Acid Substitution
  • Animals
  • Asparagine
  • Cardiomegaly (enzymology, genetics, physiopathology)
  • DNA Primers
  • Glycogen Storage Disease Type IIb (enzymology, genetics, physiopathology)
  • Heart (physiology, physiopathology)
  • Humans
  • Mice
  • Mice, Transgenic
  • NF-kappa B (metabolism)
  • Phosphorylation
  • Polymerase Chain Reaction (methods)
  • RNA (genetics, isolation & purification)
  • Threonine
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: